Methylene blue

亚甲蓝

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameMethylene blue
Drug Alias NameMethylene blue delayed-release - CosmoMethylthioninium Chloride HydrateMethylene blue tablet - Cosmomethylthioninii chloridumcloruro de metiltioninio +[22] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHemoglobins modulators
TargetsHemoglobins
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Diagnostic agentsBreast abscess +[34] 
Global Approved IndicationsPoisoningMethemoglobinemia
Approved Indications in ChinaPoisoningMethemoglobinemia
Original Approved Country/TerritoryMainland China
Original Approved Date1989/01/01
Country/TerritoryBelgiumCanadaUnited States +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesIrmandade Da Santa Casa De Misericordia De CuritibaFederal University Of Sao PauloCentro De Estudos E Pesquisa Em Emergencias Medicas E Terapia Intensiva +[20] 
Inactive CompaniesShenzhen Kangzhe Biotechnology Co LtdNorthern State Medical UniversityTaurx Therapeutics Ltd +[11] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Diagnostic agentsBreast abscess +[23] 
Inactive IndicationsStress Disorders, Post-TraumaticBipolar DisorderPostoperative Complications +[11] 

Other Information

ATC CodeV03AB17V04CG05
Related LinksWikipediaDrugBankKEGG